Fig. 2From: DNA methylation for cervical cancer screening: a training set in ChinaThe ROC curve of EPB41L3 and JAM3 methylation to differentiate cervical inflammation/cervical intraepithelial neoplasia (CIN) 1 from CIN2 or more severe cervical lesions. For EPB41L3 and JAM3, the areas under the ROC curve were 0.846 and 0.863 (95% confidence interval 0.803 to 0.889 [p < 0.001] and 0.822 to 0.903 [p < 0.001]), respectivelyBack to article page